The worldwide hypercalcemia treatment market is poised to achieve a market value of US$18.07 billion by the conclusion of 2023. With a projected compound annual growth rate (CAGR) of 11.8% over the forecast period, the market is anticipated to surge to an impressive valuation of US$55.07 billion by the year 2033. The report on the …